GlassScriptPhysician profile
Ian M Thomas
NPI 1164006615
$6,865.24
in general payments reported to CMS, 2019-2025
37 companies · $1,888 in 2025
The $1,888 reported for 2025 was more than what 95% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $717 · 2022: $1,604 · 2023: $1,401 · 2024: $1,255 · 2025: $1,888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,476 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,476.46 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,107.70 | 2021-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $806.64 | 2023-2025 | Gemtesa, Orgovyx |
| Medtronic, INC. | $708.28 | 2021-2025 | Interstim |
| Bayer Healthcare Pharmaceuticals INC. | $443.62 | 2022-2025 | |
| Pfizer INC. | $378.36 | 2021-2024 | |
| Astellas Pharma US INC | $350.63 | 2022-2025 | Xtandi, Myrbetriq |
| Dendreon Pharmaceuticals LLC | $349.85 | 2021-2025 | Provenge |
| Endo Pharmaceuticals INC. | $309.28 | 2021-2024 | Xiaflex |
| Antares Pharma, INC. | $241.59 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Myovant Sciences INC. | $237.67 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $208.53 | 2022-2023 | Prolaris |
| Tolmar Pharmaceuticals, INC. | $199.99 | 2021-2022 | |
| Endo USA, INC. | $195.22 | 2024-2025 | Xiaflex |
| Urovant Sciences INC | $158.37 | 2022 | |
| Tolmar, INC. | $157.65 | 2023-2025 | Eligard |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $145.96 | 2022-2025 | Keytruda, Welireg, Lynparza |
| Abbvie INC. | $111.10 | 2024-2025 | |
| Tempus Ai, INC | $88.38 | 2024-2025 | Xt Cdx |
| Rochester Medical Corporation | $83.17 | 2022 | |
| Verity Pharmaceuticals INC. | $82.44 | 2025 | Tlando, Trelstar |
| Urogen Pharma, INC. | $74.20 | 2025 | |
| Accord Healthcare, INC. | $48.34 | 2023 | |
| Ambu INC. | $47.93 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $47.40 | 2024-2025 | Lynparza |
| Blue Earth Diagnostics | $38.71 | 2023 | |
| Coloplast Corp | $37.02 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $26.77 | 2025 | |
| Acerus Pharmaceuticals Corporation | $25.85 | 2022 | |
| Azurity Pharmaceuticals, INC. | $20.38 | 2025 | Azmiro |
| Convatec INC. | $20.08 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $19.99 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Halozyme INC | $18.73 | 2023 | |
| Dentsply Ih Ab | $18.28 | 2025 | Lofric |
| Mission Pharmacal Company | $15.63 | 2022 | |
| Olympus America INC. | $15.30 | 2025 | Itind System |
| Laborie Medical Technologies Corp. | $13.46 | 2025 | |
| Baxter Healthcare | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.